BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1892952)

  • 1. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook.
    Gressner AM
    Eur J Clin Chem Clin Biochem; 1991 May; 29(5):293-311. PubMed ID: 1892952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
    Gressner AM; Bachem MG
    Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis.
    Gressner AM; Bachem MG
    Semin Liver Dis; 1990 Feb; 10(1):30-46. PubMed ID: 2186487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of proteoglycan synthesis in injured liver--a brief review of molecular and cellular aspects.
    Gressner AM
    Eur J Clin Chem Clin Biochem; 1994 Apr; 32(4):225-37. PubMed ID: 8038263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells.
    Geremias AT; Carvalho MA; Borojevic R; Monteiro AN
    BMC Gastroenterol; 2004 Dec; 4():30. PubMed ID: 15579200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
    Parola M; Marra F; Pinzani M
    Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic fibrogenesis].
    Loréal O; Clément B; Deugnier Y
    Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cascade-mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver.
    Gressner AM; Chunfang G
    Verh Dtsch Ges Pathol; 1995; 79():1-14. PubMed ID: 8600672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrogenesis and fibrolysis in the liver].
    Herbst H; Schuppan D; Milani S
    Verh Dtsch Ges Pathol; 1995; 79():15-27. PubMed ID: 8600680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver fibrosis. 2].
    Hahn EG; Ott U; Martini GA
    Z Gastroenterol; 1980 Oct; 18(10):507-23. PubMed ID: 6109405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC; Chung JJ
    J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
    Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis].
    Casu A; Canepa M; Nanni G
    Pathologica; 1994 Oct; 86(5):467-99. PubMed ID: 7739873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
    Gressner OA; Gressner AM
    Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.